Jacques De Greve-Greve

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Second generation Spautin-1 analogues targeting EGFR-mutant non-small cell lung cancer cells.

Second generation Spautin-1 analogues targeting EGFR-mutant non-small cell lung cancer cells.

Journal: Bioorganic & medicinal chemistry letters
Published: June 21, 2022

PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment.

PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment.

Journal: ESMO open
Published: February 01, 2022

Efficacy of a Flat Low Dose of Nivolumab in Advanced Cancer: A Retrospective Case Series.

Efficacy of a Flat Low Dose of Nivolumab in Advanced Cancer: A Retrospective Case Series.

Journal: Anticancer research
Published: November 19, 2021

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer.

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer.

Journal: Cell death & disease
Published: November 12, 2021

Addressing disparities and challenges in underserved patient populations with metastatic breast cancer in Europe.

Addressing disparities and challenges in underserved patient populations with metastatic breast cancer in Europe.

Journal: Breast (Edinburgh, Scotland)
Published: October 14, 2020

Correction to: Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab.

Correction to: Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab.

Journal: BMC medicine
Published: February 02, 2020

Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.

Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.

Journal: BMC cancer
Published: August 28, 2018

CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition.

CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition.

Journal: Oncogene
Published: June 18, 2018

Functional decline in older patients with cancer receiving chemotherapy: A multicenter prospective study.

Functional decline in older patients with cancer receiving chemotherapy: A multicenter prospective study.

Journal: Journal of geriatric oncology
Published: April 21, 2016

Combined inhibition of rho-associated protein kinase and EGFR suppresses the invasive phenotype in EGFR-dependent lung cancer cells.

Combined inhibition of rho-associated protein kinase and EGFR suppresses the invasive phenotype in EGFR-dependent lung cancer cells.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 03, 2015

Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma.

Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 28, 2014

Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment.

Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment.

Journal: Anticancer research
Published: October 03, 2014
Showing 1-12 of 15

Last Updated: 09/26/2026